Your session is about to expire
← Back to Search
Cortisone Injections for Trigger Finger
Study Summary
This trial will compare one cortisone injection to two injections for the treatment of trigger finger.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- Group 1: One injection
- Group 2: Two Injections
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Frequently Asked Questions
Are there multiple locations across this state that are administering the research project?
"Currently, seven different medical centres are actively enrolling patients in the trial. The Rothman Institute: Media location is located in Media and there's a second facility in Manahawkin; additionally, Egg Harbor Township houses another site. Moreover, four other sites exist throughout the region."
Are enrollees still being welcomed into this investigation?
"Unfortunately, recruitment for this trial has been concluded. This research was posted on May 1st 2009 and last updated February 10th 2014. If you are seeking other trials related to stenosing tenosynovitis there are currently 18 studies recruiting patients while 58 studies require participants with Two Injections."
Are there any prior studies involving the Two Injections method?
"Currently, 58 clinical trials are exploring Two Injections with 12 at Phase 3. Grand Rapids in Michigan is a hotspot for such research, though there are 5115 different locations conducting tests on this drug."
To what extent is this clinical trial populated by participants?
"Patient recruitment for this clinical trial has ceased; it was initially posted on the 5th of May, 2009 and last updated on 10 February 2014. However, 18 medical studies related to stenosing tenosynovitis are accepting participants and 58 trials involving Two Injections have open enrolment at this time."
Share this study with friends
Copy Link
Messenger